Business Context and Reporting Period
This Form 8-K is a current report filed by Pavmed Inc. on April 29, 2021. The filing serves as a Regulation FD disclosure regarding a corporate governance update at the Company's majority subsidiary, Lucid Diagnostics Inc.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel appointment and does not contain financial statements or performance data.
Material Changes
The material change disclosed is the appointment of Jacque J. Sokolov, a healthcare executive, to the board of directors of Lucid Diagnostics Inc. No financial or operational changes were reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The press release referenced in Exhibit 99.1 is limited to the board appointment announcement.
Key Facts for Investor Verification
- Verify the background and qualifications of Jacque J. Sokolov in the context of Lucid Diagnostics' strategic goals.
- Confirm the extent of Pavmed Inc.'s ownership stake in Lucid Diagnostics Inc. to understand the impact of this board appointment.
- Review the full text of the press release (Exhibit 99.1) for any additional context not summarized in the 8-K.